Latest News

Focusing on cutting-edge technologies and research advancements,
sharing Aniphe BioLab’s achievements in scientific innovation, Professional insights
and practical experience in the fields of laboratory animals and preclinical research.

Publish an article

2026-10-29

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

2026-10-29

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

2026-08-12

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

2026-08-12

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

Good News | Jiangsu Aniphe BioLab has successfully been certified as a “National High-Tech Enterprise”!

Recently, the Office of the National Leading Group for the Administration of High-Tech Enterprise Recognition announced the list of the second batch of high-tech enterprises in Jiangsu Province for 2023. Jiangsu Aniphe BioLab Co., Ltd. has been proudly listed among them and has received national-level high-tech enterprise certification—an important milestone in the company’s development journey!

Public Notice of Determination

Image source: High-Tech Enterprise Recognition and Management Website.

The designation of a National High-Tech Enterprise is a national-level honor jointly initiated by the Ministry of Science and Technology, the Ministry of Finance, and the State Taxation Administration. It entails rigorous review and assessment based on a comprehensive evaluation of factors such as the enterprise’s proprietary intellectual property, R&D investment, investment in high-tech products, talent structure, organizational management capabilities, and growth‑related indicators.

Registration List

Image source: High-Tech Enterprise Recognition and Management Website.

Having been recognized as a “High-Tech Enterprise,” this honor underscores the strength of Aniphe BioLab’s R&D capabilities. Looking ahead, we will proactively fulfill the social responsibilities expected of a high-tech enterprise, hold ourselves to even higher standards, continuously enhance our technological expertise and core competitiveness, and deliver superior products and services to our customers.

About Aniphe BioLab

Image source: Aniphe BioLab

Jiangsu Aniphe BioLab Co., Ltd. ( Aniphe BioLab Inc. was established in 2018 and has since developed a comprehensive SPF‑grade laboratory animal facility that integrates animal production and experimental services, covering research areas such as oncology, neuroscience, and metabolism. The facility spans a total area of 827 square meters.

Image source: Aniphe BioLab

Service Business and Products

I. Disease animal model Aging model, neurological disease model, CDX/PDX models of metabolic diseases.

II. Cellular and Molecular Protein Experiment Stable expression /In vitro drug screening and assessment of cell proliferation and apoptosis in gene-knockout cell lines.

III. Imaging-Based Behavioral Monitoring of Small Animals In vivo imaging, Micro-CT scanning, the water maze, ultrasound, metabolic cages, and others.

IV. Efficacy Evaluation Professional preclinical in vivo and in vitro pharmacological evaluation, offering end-to-end R&D outsourcing services.

V. Pathological and biochemical testing and analysis High‑efficiency detection, high throughput, precise and reliable, with customizable services.

VI. Laboratory Animal Resource Bank (Custodial Breeding and Maintenance) SPF-grade clean animal facility, for breeding, model generation, drug administration, genetic identification, and biomarker analysis, among other applications. 。